1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: C Reactive Protein Testing Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. C Reactive Protein Testing Market, by Assay Type
8.1.1. Immunoturbidimetric Assay
8.1.1.1. Market Revenue and Forecast
8.1.2. ELISA
8.1.2.1. Market Revenue and Forecast
8.1.3. Clinical
8.1.3.1. Market Revenue and Forecast
8.1.4. Nonclinical
8.1.4.1. Market Revenue and Forecast
8.1.5. Chemiluminescence Immunoassay
8.1.5.1. Market Revenue and Forecast
8.1.6. Others
8.1.6.1. Market Revenue and Forecast
9.1. C Reactive Protein Testing Market, by Detection Range
9.1.1. hs-CRP
9.1.1.1. Market Revenue and Forecast
9.1.2. Conventional CRP
9.1.2.1. Market Revenue and Forecast
9.1.3. cCRP
9.1.3.1. Market Revenue and Forecast
10.1. C Reactive Protein Testing Market, by Disease Area
10.1.1. Cardiovascular Diseases
10.1.1.1. Market Revenue and Forecast
10.1.2. Cancer
10.1.2.1. Market Revenue and Forecast
10.1.3. Rheumatoid Arthritis
10.1.3.1. Market Revenue and Forecast
10.1.4. Inflammatory Bowel Disease
10.1.4.1. Market Revenue and Forecast
10.1.5. Endometriosis
10.1.5.1. Market Revenue and Forecast
10.1.6. Lupus
10.1.6.1. Market Revenue and Forecast
10.1.7. Others
10.1.7.1. Market Revenue and Forecast
11.1. C Reactive Protein Testing Market, by End-use
11.1.1. Clinics
11.1.1.1. Market Revenue and Forecast
11.1.2. Hospitals
11.1.2.1. Market Revenue and Forecast
11.1.3. Laboratories
11.1.3.1. Market Revenue and Forecast
11.1.4. Assisted Living Healthcare Facilities
11.1.4.1. Market Revenue and Forecast
11.1.5. Homecare Settings
11.1.5.1. Market Revenue and Forecast
11.1.6. Others
11.1.6.1. Market Revenue and Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Assay Type
12.1.2. Market Revenue and Forecast, by Detection Range
12.1.3. Market Revenue and Forecast, by Disease Area
12.1.4. Market Revenue and Forecast, by End-use
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Assay Type
12.1.5.2. Market Revenue and Forecast, by Detection Range
12.1.5.3. Market Revenue and Forecast, by Disease Area
12.1.5.4. Market Revenue and Forecast, by End-use
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Assay Type
12.1.6.2. Market Revenue and Forecast, by Detection Range
12.1.6.3. Market Revenue and Forecast, by Disease Area
12.1.6.4. Market Revenue and Forecast, by End-use
12.2. Europe
12.2.1. Market Revenue and Forecast, by Assay Type
12.2.2. Market Revenue and Forecast, by Detection Range
12.2.3. Market Revenue and Forecast, by Disease Area
12.2.4. Market Revenue and Forecast, by End-use
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Assay Type
12.2.5.2. Market Revenue and Forecast, by Detection Range
12.2.5.3. Market Revenue and Forecast, by Disease Area
12.2.5.4. Market Revenue and Forecast, by End-use
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Assay Type
12.2.6.2. Market Revenue and Forecast, by Detection Range
12.2.6.3. Market Revenue and Forecast, by Disease Area
12.2.6.4. Market Revenue and Forecast, by End-use
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Assay Type
12.2.7.2. Market Revenue and Forecast, by Detection Range
12.2.7.3. Market Revenue and Forecast, by Disease Area
12.2.7.4. Market Revenue and Forecast, by End-use
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Assay Type
12.2.8.2. Market Revenue and Forecast, by Detection Range
12.2.8.3. Market Revenue and Forecast, by Disease Area
12.2.8.4. Market Revenue and Forecast, by End-use
12.3. APAC
12.3.1. Market Revenue and Forecast, by Assay Type
12.3.2. Market Revenue and Forecast, by Detection Range
12.3.3. Market Revenue and Forecast, by Disease Area
12.3.4. Market Revenue and Forecast, by End-use
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Assay Type
12.3.5.2. Market Revenue and Forecast, by Detection Range
12.3.5.3. Market Revenue and Forecast, by Disease Area
12.3.5.4. Market Revenue and Forecast, by End-use
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Assay Type
12.3.6.2. Market Revenue and Forecast, by Detection Range
12.3.6.3. Market Revenue and Forecast, by Disease Area
12.3.6.4. Market Revenue and Forecast, by End-use
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Assay Type
12.3.7.2. Market Revenue and Forecast, by Detection Range
12.3.7.3. Market Revenue and Forecast, by Disease Area
12.3.7.4. Market Revenue and Forecast, by End-use
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Assay Type
12.3.8.2. Market Revenue and Forecast, by Detection Range
12.3.8.3. Market Revenue and Forecast, by Disease Area
12.3.8.4. Market Revenue and Forecast, by End-use
12.4. MEA
12.4.1. Market Revenue and Forecast, by Assay Type
12.4.2. Market Revenue and Forecast, by Detection Range
12.4.3. Market Revenue and Forecast, by Disease Area
12.4.4. Market Revenue and Forecast, by End-use
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Assay Type
12.4.5.2. Market Revenue and Forecast, by Detection Range
12.4.5.3. Market Revenue and Forecast, by Disease Area
12.4.5.4. Market Revenue and Forecast, by End-use
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Assay Type
12.4.6.2. Market Revenue and Forecast, by Detection Range
12.4.6.3. Market Revenue and Forecast, by Disease Area
12.4.6.4. Market Revenue and Forecast, by End-use
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Assay Type
12.4.7.2. Market Revenue and Forecast, by Detection Range
12.4.7.3. Market Revenue and Forecast, by Disease Area
12.4.7.4. Market Revenue and Forecast, by End-use
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Assay Type
12.4.8.2. Market Revenue and Forecast, by Detection Range
12.4.8.3. Market Revenue and Forecast, by Disease Area
12.4.8.4. Market Revenue and Forecast, by End-use
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Assay Type
12.5.2. Market Revenue and Forecast, by Detection Range
12.5.3. Market Revenue and Forecast, by Disease Area
12.5.4. Market Revenue and Forecast, by End-use
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Assay Type
12.5.5.2. Market Revenue and Forecast, by Detection Range
12.5.5.3. Market Revenue and Forecast, by Disease Area
12.5.5.4. Market Revenue and Forecast, by End-use
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Assay Type
12.5.6.2. Market Revenue and Forecast, by Detection Range
12.5.6.3. Market Revenue and Forecast, by Disease Area
12.5.6.4. Market Revenue and Forecast, by End-use
13.1. Thermo Fisher Scientific, Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. F. Hoffmann-La Roche Ltd.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Danaher
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Quest Diagnostics
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Siemens Healthineers AG
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Abbott
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Merck KGaA
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Zoetis
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Ortho Clinical Diagnostics
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Getein Biotech, Inc.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
